NBDA's Biomarker R&D Modules Overview

Successful biomarkers should move systematically and seamlessly through specific R&D “modules” - from early discovery to clinical validation. NBDA’s end-to-end systems approach is based on working with experts from all affected multi-sector stakeholder communities to build an in-depth understanding of the existing barriers in each of these “modules” to support decision making at each juncture.  Following extensive “due diligence” the NBDA works with all stakeholders to assemble and/or create the enabling standards (guidelines, best practices, SOPs) needed to support clinically relevant and robust biomarker development.

NBDA Events

View All >>
Event Image

Upcoming Events:

Workshop VI: December 2014
Workshop V: July 2014

About NBDA

More >>

Mission: Collaboratively creating the NBDA Standards* required for end-to-end, evidence - based biomarker development to advance precision (personalized) medicine.
NBDA Standards include but are not limited to: “official existing standards”, guidelines, principles, standard operating procedures (SOP), and best practices.

"The NBDA's vision is not to just relegate the current biomarker development processes to history, but also to serve as a working example of what convergence of purpose, scientific knowledge and collaboration can accomplish."